Literature DB >> 24481638

Sca1⁺ murine pituitary adenoma cells show tumor-growth advantage.

Ines Donangelo1, Song-Guang Ren, Tamar Eigler, Clive Svendsen, Shlomo Melmed.   

Abstract

The role of tumor stem cells in benign tumors such as pituitary adenomas remains unclear. In this study, we investigated whether the cells within pituitary adenomas that spontaneously develop in Rb+/- mice are hierarchically distributed with a subset being responsible for tumor growth. Cells derived directly from such tumors grew as spheres in serum-free culture medium supplemented with epidermal growth factor and basic fibroblast growth factor. Some cells within growing pituitary tumor spheres (PTS) expressed common stem cell markers (Sca1, Sox2, Nestin, and CD133), but were devoid of hormone-positive differentiated cells. Under subsequent differentiating conditions (matrigel-coated growth surface), PTS expressed all six pituitary hormones. We next searched for specific markers of the stem cell population and isolated a Sca1(+) cell population that showed increased sphere formation potential, lower mRNA hormone expression, higher expression of stem cell markers (Notch1, Sox2, and Nestin), and increased proliferation rates. When transplanted into non-obese diabetic-severe combined immunodeficiency gamma mice brains, Sca1(+) pituitary tumor cells exhibited higher rates of tumor formation (brain tumors observed in 11/11 (100%) vs 7/12 (54%) of mice transplanted with Sca1(+) and Sca1(-) cells respectively). Magnetic resonance imaging and histological analysis of brain tumors showed that tumors derived from Sca1(+) pituitary tumor cells were also larger and plurihormonal. Our findings show that Sca1(+) cells derived from benign pituitary tumors exhibit an undifferentiated expression profile and tumor-proliferative advantages, and we propose that they could represent putative pituitary tumor stem/progenitor cells.

Entities:  

Keywords:  neoplasia; pathogenesis; pituitary

Mesh:

Substances:

Year:  2014        PMID: 24481638      PMCID: PMC3978815          DOI: 10.1530/ERC-13-0229

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  40 in total

1.  Effects of an Rb mutation in the mouse.

Authors:  T Jacks; A Fazeli; E M Schmitt; R T Bronson; M A Goodell; R A Weinberg
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

2.  Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system.

Authors:  B A Reynolds; S Weiss
Journal:  Science       Date:  1992-03-27       Impact factor: 47.728

3.  Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell.

Authors:  B A Reynolds; S Weiss
Journal:  Dev Biol       Date:  1996-04-10       Impact factor: 3.582

4.  Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.

Authors:  D J Simpson; N A Hibberts; A M McNicol; R N Clayton; W E Farrell
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

5.  Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family.

Authors:  M van de Rijn; S Heimfeld; G J Spangrude; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

Review 6.  Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

7.  Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.

Authors:  Rossella Galli; Elena Binda; Ugo Orfanelli; Barbara Cipelletti; Angela Gritti; Simona De Vitis; Roberta Fiocco; Chiara Foroni; Francesco Dimeco; Angelo Vescovi
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

8.  A dynamic switch in Rb+/- mediated neuroendocrine tumorigenesis.

Authors:  Sandra W Leung; Elzbieta H Wloga; Alejandro F Castro; Thao Nguyen; Roderick T Bronson; Lili Yamasaki
Journal:  Oncogene       Date:  2004-04-22       Impact factor: 9.867

9.  Clonal origin of pituitary adenomas.

Authors:  V Herman; J Fagin; R Gonsky; K Kovacs; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

10.  Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture.

Authors:  Devaveena Dey; Meera Saxena; Anurag N Paranjape; Visalakshi Krishnan; Rajashekhar Giraddi; M Vijaya Kumar; Geetashree Mukherjee; Annapoorni Rangarajan
Journal:  PLoS One       Date:  2009-04-24       Impact factor: 3.240

View more
  10 in total

Review 1.  Pathogenesis of non-functioning pituitary adenomas.

Authors:  Maria Chiara Zatelli
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

2.  Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.

Authors:  Roberto Würth; Federica Barbieri; Alessandra Pattarozzi; Germano Gaudenzi; Federico Gatto; Pietro Fiaschi; Jean-Louis Ravetti; Gianluigi Zona; Antonio Daga; Luca Persani; Diego Ferone; Giovanni Vitale; Tullio Florio
Journal:  Mol Neurobiol       Date:  2016-08-11       Impact factor: 5.590

3.  The identification of human pituitary adenoma-initiating cells.

Authors:  Branavan Manoranjan; Sujeivan Mahendram; Saleh A Almenawer; Chitra Venugopal; Nicole McFarlane; Robin Hallett; Thusyanth Vijayakumar; Almunder Algird; Naresh K Murty; Doron D Sommer; John P Provias; Kesava Reddy; Sheila K Singh
Journal:  Acta Neuropathol Commun       Date:  2016-11-28       Impact factor: 7.801

4.  Expression and clinical significance of EGR-1 and PTEN in the pituitary tumors of elderly patients.

Authors:  Shu-Wen Sun; Xiao-Mei Fang; Yi-Fei Li; Qing-Bo Wang; Yu-Xin Li
Journal:  Oncol Lett       Date:  2017-06-13       Impact factor: 2.967

5.  Expression of Stem Cell Markers and Dopamine D2 Receptors in Human and Rat Prolactinomas.

Authors:  Zhichao Gao; Lin Cai; Jianglong Lu; Chengde Wang; Qun Li; Jian Chen; Xiaoxiao Song; Xianbin Chen; Linlin Zhang; Weiming Zheng; Zhipeng Su
Journal:  Med Sci Monit       Date:  2017-04-15

Review 6.  Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior.

Authors:  Giovanna Mantovani; Elena Giardino; Donatella Treppiedi; Rosa Catalano; Federica Mangili; Anna Spada; Maura Arosio; Erika Peverelli
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-25       Impact factor: 5.555

7.  Primary Cultures from Human GH-secreting or Clinically Non-functioning Pituitary Adenomas.

Authors:  Roberto Würth; Alessandra Pattarozzi; Federica Barbieri; Tullio Florio
Journal:  Bio Protoc       Date:  2018-04-05

Review 8.  Concise Review: Paracrine Role of Stem Cells in Pituitary Tumors: A Focus on Adamantinomatous Craniopharyngioma.

Authors:  Juan Pedro Martinez-Barbera; Cynthia L Andoniadou
Journal:  Stem Cells       Date:  2016-01-13       Impact factor: 6.277

Review 9.  Stem/progenitor cells in pituitary organ homeostasis and tumourigenesis.

Authors:  Scott Haston; Saba Manshaei; Juan Pedro Martinez-Barbera
Journal:  J Endocrinol       Date:  2017-08-30       Impact factor: 4.286

Review 10.  Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells.

Authors:  Roberto Würth; Stefano Thellung; Alessandro Corsaro; Federica Barbieri; Tullio Florio
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-20       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.